|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
3
|
Resverlogix Corp.
|
Dec 22, 2020 09:35AM
|
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
11
|
Resverlogix Corp.
|
Dec 22, 2020 09:02AM
|
|
Re: Zhlcf
|
1
|
Zenith Epigenetics
|
Dec 17, 2020 03:36PM
|
|
Re: ZHCLF up 290% to $0.16...question
|
1
|
Zenith Epigenetics
|
Dec 16, 2020 12:27PM
|
|
Re: ZHCLF up 290% to $0.16...question
|
3
|
Zenith Epigenetics
|
Dec 16, 2020 11:54AM
|
|
Re: ZHCLF up 290% to $0.16...question
|
3
|
Zenith Epigenetics
|
Dec 16, 2020 11:45AM
|
|
Re: ZHCLF up 290% to $0.16...question
|
|
Zenith Epigenetics
|
Dec 14, 2020 04:38PM
|
|
Re: Existing Security Holder Prospectus Exemption
|
3
|
Resverlogix Corp.
|
Dec 14, 2020 04:09PM
|
|
Re: ZHCLF up 290% to $0.16...question
|
3
|
Zenith Epigenetics
|
Dec 14, 2020 03:45PM
|
|
Re: ZHCLF up 290% to $0.16...question
|
1
|
Zenith Epigenetics
|
Dec 14, 2020 03:11PM
|
|
Re: ZHCLF up 290% to $0.16...question
|
2
|
Zenith Epigenetics
|
Dec 14, 2020 02:34PM
|
|
Re: Existing Security Holder Prospectus Exemption
|
2
|
Resverlogix Corp.
|
Dec 14, 2020 12:59PM
|
|
Re: Institutional Investors
|
1
|
Resverlogix Corp.
|
Dec 13, 2020 07:49PM
|
|
Re: Name Confusion
|
1
|
Zenith Epigenetics
|
Dec 12, 2020 09:03PM
|
|
Re: Institutional Investors
|
4
|
Resverlogix Corp.
|
Dec 12, 2020 06:06PM
|
|
Re: Name Confusion
|
1
|
Zenith Epigenetics
|
Dec 12, 2020 05:32PM
|
|
Re: Name Confusion
|
3
|
Zenith Epigenetics
|
Dec 12, 2020 05:22PM
|
|
Re: Name Confusion
|
2
|
Zenith Epigenetics
|
Dec 12, 2020 02:35PM
|
|
Re: Name Confusion
|
5
|
Zenith Epigenetics
|
Dec 11, 2020 11:13PM
|
|
Re: RVXOT any thoughts
|
8
|
Resverlogix Corp.
|
Dec 09, 2020 09:22PM
|
